.AN2 Therapies is rethinking its own company in action to poor midphase data, vowing to lay off half...
.Merck & Co. is paying $700 million upfront to test Amgen in a blood stream cancer cells market. ...
.Along With Gilead Sciences almost an FDA selection for its liver disease medicine seladelpar, the f...
.CEO David Ricks can observe the firms establishing camping tents at basecamp behind Eli Lilly in an...
.Mattress Liquidators has actually transformed Entero Therapies white as a slab. The collector got E...
.Exelixis is losing hope on its own cells element (TF)- targeting antibody-drug conjugate after wrap...
.3 full weeks after Roche's Genentech device walked away from an SHP2 prevention pact, Relay Therape...
.Stoke Rehabs' Dravet disorder medication has actually been freed from a predisposed grip, removing ...
.Tough Biotech Partner Editor Gabrielle Masson presented the 2024 course of Tough 15 champions on th...
.Novo Nordisk has actually axed its own once-monthly double GLP-1/ GIP receptor agonist, ending (PDF...